During the past decade, Kasturba Medical College and Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kasturba Medical College and Hospital" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Cadila Pharnmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kasturba Medical College and Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Asian Clinical Trials" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Kasturba Medical College and Hospital" are "Crohn's Disease" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Ulcerative Colitis" (2 trials), "Bladder Cancer" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Kasturba Medical College and Hospital" in a lesser frequency.

Most popular intervention types in "Kasturba Medical College and Hospital" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (4 trials), "Baricitinib" (2 trials), "ATM-AVI" (1 trials) and "Angiotensin Receptor Blockers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kasturba Medical College and Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Kasturba Medical College and Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Kasturba Medical College and Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kasturba Medical College and Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".